ly 274614 has been researched along with nalbuphine in 1 studies
Studies (ly 274614) | Trials (ly 274614) | Recent Studies (post-2010) (ly 274614) | Studies (nalbuphine) | Trials (nalbuphine) | Recent Studies (post-2010) (nalbuphine) |
---|---|---|---|---|---|
96 | 0 | 15 | 793 | 269 | 185 |
Protein | Taxonomy | ly 274614 (IC50) | nalbuphine (IC50) |
---|---|---|---|
Mu-type opioid receptor | Homo sapiens (human) | 0.0578 | |
Delta-type opioid receptor | Homo sapiens (human) | 1.1195 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.097 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dykstra, LA; Fischer, BD | 1 |
1 other study(ies) available for ly 274614 and nalbuphine
Article | Year |
---|---|
Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Butorphanol; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Interactions; Hot Temperature; Isoquinolines; Male; Mice; Mice, Inbred BALB C; Morphine; N-Methylaspartate; Nalbuphine; Receptors, Opioid | 2006 |